University of Salerno clinical trials
University of Salerno is the lead sponsor of 6 current clinical trials in our Italy register. 4 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Vericiguat. The most-studied condition is Heart Failure.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by University of Salerno
6 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
NCT06589063 · ClinicalTrials.gov ↗ · Low Flow, Low Gradient Aortic Stenosis
|
Observational | Recruiting | 2024-03 | Italy |
|
Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
NCT06821256 · ClinicalTrials.gov ↗ · Multiple System Atrophy - Cerebellar Subtype (MSA-C)
|
Not applicable | Recruiting | 2023-07 | Italy |
|
Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure
NCT07023536 · ClinicalTrials.gov ↗ · Heart Failure
|
Observational | Recruiting | 2025-06 | Italy |
|
AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices
NCT06909682 · ClinicalTrials.gov ↗ · Chronic Heart Failure, Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction (HFrEF)
|
Observational | Recruiting | 2025-08 | Italy |
|
Metabolic Changes in Heart Failure Patients Treated With Vericiguat
NCT07901270 · ClinicalTrials.gov ↗ · Heart Failure, Worsening Heart Failure, Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat |
Observational | Not yet open | 2026-11 | Italy |
|
Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients
NCT07273669 · ClinicalTrials.gov ↗ · AORTIC VALVE DISEASES, Mitral Valve Failure
|
Not applicable | Active, closed | 2025-09 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in University of Salerno trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in University of Salerno trials
11 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 6 | 4 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Heart Failure
Sponsors with the most current trials registered for this condition.
Questions about University of Salerno trials
How many clinical trials does University of Salerno sponsor?
University of Salerno is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.
Are University of Salerno trials recruiting?
Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is University of Salerno testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Vericiguat (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.